Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors

被引:93
作者
Liu, F [1 ]
Ma, XH
Ule, J
Bibb, JA
Nishi, A
DeMaggio, AJ
Yan, Z
Nairn, AC
Greengard, P
机构
[1] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA
[2] ICOS Corp, Bothell, WA 98021 USA
[3] Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka 8300011, Japan
[4] SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA
关键词
D O I
10.1073/pnas.191353898
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cyclin-dependent kinase 5 (Cdk5) is a multifunctional neuronal protein kinase that is required for neurite outgrowth and cortical lamination and that plays an important role in dopaminergic signaling in the neostriatum through phosphorylation of Thr-75 of DARPP-32 (dopamine and cAMP-regulated phosphoprotein, molecular mass 32 kDa). Casein kinase 1 (CK1) has been implicated in a variety of cellular functions such as DNA repair, circadian rhythm, and intracellular trafficking. In the neostriatum, CK1 has been found to phosphorylate Ser-137 of DARPP-32. However, first messengers for the regulation of Cdk5 or CK1 have remained unknown. Here we report that both Cdk5 and CK1 are regulated by metabotropic glutamate receptors (mGluRs) in neostriatal neurons. (S)3,5-dihydroxyphenylglycine (DHPG), an agonist for group I mGluRs, increased Cdk5 and CK1 activities in neostriatal slices, leading to the enhanced phosphorylation of Thr-75 and Ser-137 of DARPP-32, respectively. The effect of DHPG on Thr-75, but not on Ser-137, was blocked by a Cdk5-specific inhibitor, butyrolactone. In contrast, the effects of DHPG on both Thr-75 and Ser-137 were blocked by CK1-7 and IC261, specific inhibitors of CK1, suggesting that activation of Cdk5 by mGluRs requires CK1 activity. In support of this possibility, the DHPG-induced increase in Cdk5 activity, measured in extracts of neostriatal slices, was abolished by CK1-7 and IC261. Treatment of acutely dissociated neurons with DHPG enhanced voltage-dependent Ca2+ currents. This enhancement was eliminated by either butyrolactone or CK1-7 and was absent in DARPP-32 knockout mice. Together these results indicate that a CK1-Cdk5-DARPP-32 cascade may be involved in the regulation by mGluR agonists of Ca2+ channels.
引用
收藏
页码:11062 / 11068
页数:7
相关论文
共 47 条
[31]   Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells [J].
Nath, R ;
Davis, M ;
Probert, AW ;
Kupina, NC ;
Ren, XD ;
Schielke, GP ;
Wang, KKW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (01) :16-21
[32]   Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders? [J].
Nicoletti, F ;
Bruno, V ;
Copani, A ;
Casabona, G ;
Knopfel, T .
TRENDS IN NEUROSCIENCES, 1996, 19 (07) :267-271
[33]   Amplification of dopaminergic signaling by a positive feedback loop [J].
Nishi, A ;
Bibb, JA ;
Snyder, GL ;
Higashi, H ;
Nairn, AC ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12840-12845
[34]  
Nishi A, 1997, J NEUROSCI, V17, P8147
[35]   Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death [J].
Ohshima, T ;
Ward, JM ;
Huh, CG ;
Longenecker, G ;
Veeranna ;
Pant, HC ;
Brady, RO ;
Martin, LJ ;
Kulkarni, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :11173-11178
[36]   Suppressors of YCK-encoded yeast casein kinase 1 deficiency define the four subunits of a novel clathrin AP-like complex [J].
Panek, HR ;
Stepp, JD ;
Engle, HM ;
Marks, KM ;
Tan, PK ;
Lemmon, SK ;
Robinson, LC .
EMBO JOURNAL, 1997, 16 (14) :4194-4204
[37]   Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration [J].
Patrick, GN ;
Zukerberg, L ;
Nikolic, M ;
de la Monte, S ;
Dikkes, P ;
Tsai, LH .
NATURE, 1999, 402 (6762) :615-622
[38]  
PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G
[39]  
ROBERTS PJ, 1995, NEUROPHARMACOLOGY, V34, P813, DOI 10.1016/0028-3908(95)00094-M
[40]   Pharmacological characterization of metabotropic glutamate receptors linked to the inhibition of adenylate cyclase activity in rat striatal slices [J].
Schaffhauser, H ;
Cartmell, J ;
JakobRotne, R ;
Mutel, V .
NEUROPHARMACOLOGY, 1997, 36 (07) :933-940